LLGL1 (LLGL scribble cell polarity complex component 1) functions as a scaffolding protein that regulates apical-basal polarity establishment in epithelial cells 1. The protein operates through a sophisticated capture-and-release mechanism with aPKC-Par6, where LLGL1 forms a stable complex that mutually inhibits both kinase and substrate activities until released by active Cdc42 and Crumbs signaling 2. LLGL1 demonstrates context-dependent functions across different cell types. In hematopoietic stem cells (HSCs), loss of LLGL1 paradoxically increases HSC fitness and self-renewal capacity, unlike its complex partner Scrib which impairs HSC function 3. However, in acute myeloid leukemia (AML), LLGL1 is required for leukemia propagation, maintaining stemness-associated gene expression including HoxA genes, and its inactivation induces differentiation toward a GMP-like phenotype 4. In solid tumors, LLGL1 loss correlates with cancer progression - it is associated with diffuse gastric cancer and peritoneal metastases, co-expressing with E-cadherin and promoting cellular adhesion 5. LLGL1 is also regulated by microRNA-652-3p, which targets it to modulate cell polarity mechanisms affecting cancer metastasis 6. These findings establish LLGL1 as having diverse, cell-type-specific roles in polarity regulation and cancer biology.